Search Results - James M. Reuben

Refine Results
  1. 1
    Intervertebral disc degeneration adjacent to a lumbar fusion: An experimental rabbit model

    Intervertebral disc degeneration adjacent to a lumbar fusion: An experimental rabbit model by Frank M. Phillips, James M. Reuben, F. Todd Wetzel

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells

    Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells by Anupam Kumar, Hui Gao, Jia Xu, James M. Reuben, Dihua Yu, Kapil Mehta

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions

    Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions by Juan P. Cata, H. Wang, Vijaya Gottumukkala, James M. Reuben, Daniel I. Sessler

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts

    Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts by Radka Saldova, James M. Reuben, Umi Marshida Abd Hamid, Pauline M. Rudd, Massimo Cristofanilli

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells

    Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells by Anupam Kumar, Jia Xu, Samuel W. Brady, Hui Gao, Dihua Yu, James M. Reuben, Kapil Mehta

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

    Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome by Luis Fayad, Michael J. Keating, James M. Reuben, Susan O’Brien, Bang‐Ning Lee, Susan Lerner, Razelle Kurzrock

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Treatment of hairy cell leukemia with recombinant alpha-interferon

    Treatment of hairy cell leukemia with recombinant alpha-interferon by JR Quesada, E. Hersh, John T. Manning, James M. Reuben, M Keating, Edward F. Schnipper, Loretta M. Itri, Gutterman Ju

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation

    Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation by Xin Shelley Wang, Qiuling Shi, Lori Williams, Charles S. Cleeland, Gary M. Mobley, James M. Reuben, Bang‐Ning Lee, Sergio Giralt

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer by Julie E. Lang, Kailash Mosalpuria, Massimo Cristofanilli, Savitri Krishnamurthy, James M. Reuben, Balraj Singh, Isabelle Bedrosian, Funda Meric‐Bernstam, Anthony Lucci

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study

    The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study by Sriram Yennurajalingam, Jie Willey, J. Lynn Palmer, Julio Allo, Egidio Del Fabbro, Evan N. Cohen, Sanda Tin, James M. Reuben, Éduardo Bruera

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

    Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis by Alok C. Bharti, Shishir Shishodia, James M. Reuben, Donna Weber, Raymond Alexanian, Saroj Raj-Vadhan, Zeev Estrov, Moshe Talpaz, Bharat B. Aggarwal

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism

    Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism by Bisrat G. Debeb, Lara Lacerda, Richard Larson, Adam R. Wolfe, Savitri Krishnamurthy, James M. Reuben, Naoto T. Ueno, Michael Z. Gilcrease, Wendy A. Woodward

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer

    Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer by Ugo De Giorgi, Michal Mego, Emanuela Scarpi, Antonio Giordano, Mario Giuliano, Vicente Valero, Ricardo H. Álvarez, Naoto T. Ueno, Massimo Cristofanilli, James M. Reuben

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor

    Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor by CF LeMaistre, C Meneghetti, Michael G. Rosenblum, James M. Reuben, K Parker, James O. Shaw, A. B. Deisseroth, Thasia Woodworth, DR Parkinson

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor

    Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor by CF LeMaistre, C Meneghetti, Michael G. Rosenblum, James M. Reuben, K Parker, James O. Shaw, A. B. Deisseroth, Thasia Woodworth, DR Parkinson

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Phenotypic and molecular heterogeneity in Philadelphia chromosome- positive acute leukemia

    Phenotypic and molecular heterogeneity in Philadelphia chromosome- positive acute leukemia by C Hirsch-Ginsberg, Craig C. Childs, KS Chang, Miloslav Beran, Ann Cork, James M. Reuben, EJ Freireich, LC Chang, FJ Bollum, José M. Trujillo

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Detection of minimal residual disease in blood and bone marrow in early stage breast cancer

    Detection of minimal residual disease in blood and bone marrow in early stage breast cancer by Savitri Krishnamurthy, Massimo Cristofanilli, Balraj Singh, James M. Reuben, Hui Gao, Evan N. Cohen, Eleni Andreopoulou, Carolyn Hall, Ashutosh Lodhi, Summer Jackson, Anthony Lucci

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer

    Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer by Anne F. Schott, Lori J. Goldstein, Massimo Cristofanilli, Pier Adelchi Ruffini, Susan McCanna, James M. Reuben, Raymond P. Perez, Giraldo Kato, Max S. Wicha

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    <sup>18</sup>F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer

    <sup>18</sup>F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer by Ugo De Giorgi, Michal Mego, Eric Rohren, Ping Liu, Beverly C. Handy, James M. Reuben, Homer A. Macapinlac, Gabriel N. Hortobágyi, Massimo Cristofanilli, Naoto T. Ueno

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Circulating Tumor Cells With Epithelial–to–mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer

    Circulating Tumor Cells With Epithelial–to–mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer by Michal Mego, Marián Karaba, Gabriel Minárik, Juraj Benca, Silvia Jurišová, Tatiana Sedláčková, Denisa Manasova, Katarína Kaľavská, Daniel Pinďák, Massimo Cristofanilli, James M. Reuben, Jozef Mardiak

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: